<b>Conclusions</b>: <b>CCL</b>, particularly its active component quercetin, may inhibit ccRCC progression via inhibiting MMP9-mediated M2 macrophage polarization. This evidence concerns the gene MMP9 and nonpapillary renal cell carcinoma.